Acadia Pharmaceuticals buy Deutsche Bank Aktiengesellschaft
Start price
21.05.25
/
50%
€19.69
Target price
21.05.26
€30.98
Performance (%)
-7.14%
End price
22.05.26
€18.28
Summary
This prediction ended on 22.05.26 with a price of €18.28. With a performance of -7.14%, the BUY prediction by Deutsche_Bank_Aktien finished with a loss. Deutsche_Bank_Aktien has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 1.684% | 1.684% | 12.800% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten